Author:
Editor(s):
ULY CLINIC
ULY CLINIC
Bradypnea

Bradypnea is a pattern of regular but abnormally slow respirations — fewer than 10 breaths per minute. It often precedes apnea or respiratory arrest and requires immediate intervention.
Causes
Neurologic & Metabolic
Increased intracranial pressure (ICP)
Neurologic infections, tumors, stroke, or trauma
Diabetic ketoacidosis (late stage)
Hepatic failure (end-stage)
Renal failure (end-stage)
Respiratory failure
Drug-Induced
Opioid overdose (most common)
Sedatives, barbiturates, phenothiazines
Drug interactions (especially with alcohol)
Assessment
Vital Signs: Monitor closely
Neurologic Evaluation:
Pupil size and reactivity
Level of consciousness (LOC)
Motor function
History: Ask about:
Drug use (type, amount, route, time)
Chronic illnesses (diabetes, renal/hepatic issues)
CNS disease or trauma
Physical Signs:
Needle marks
Fruity breath (DKA)
Fetor hepaticus
Asterixis
Uremic frost
Cyanosis
Emergency interventions
Stimulation: Shake and instruct patient to breathe
Positioning: Lateral or head-up 30° to prevent aspiration
Airway Management:
Prepare for suction, intubation, ventilation
Apply apnea monitor and pulse oximeter
Medication:
Administer naloxone IV if opioid overdose is suspected
Avoid CNS depressants
Oxygen therapy – use cautiously in COPD patients
Investigations:
ABG, electrolytes, drug screen
Chest X-ray
Possible head CT
Special considerations
Pediatrics
Definition varies by age – respiratory rates are naturally higher.
Geriatrics
Higher risk due to polypharmacy and altered drug metabolism.
Extra caution with CNS depressants.
Patient Counseling
Educate about:
Risks of opioid therapy and overdose
Early signs of bradypnea and when to seek help
The treatment plan and importance of follow-up
Classic Sign of Increased ICP
Cushing’s Triad:
Bradypnea
Bradycardia
Hypertension
References
Chung, F., Abrishami, A., & Khajehdehi, A. (2010). A systematic review of screening questionnaires for obstructive sleep apnea. Canadian Journal of Anaesthesia, 57(5), 423–438.
Dahan, A., Aarts, L., & Smith, T. W. (2010). Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology, 112(1), 226–238.